Search
moon
sun

Introduction and epidemiology

A1. Fever

(1) ์ •์ƒ ์ฒด์˜จ๋ณด๋‹ค ์ฒด์˜จ์ด ๋†’์„ ๊ฒฝ์šฐ fever๋กœ ๊ฐ„์ฃผํ•œ๋‹ค.
(2) Age group์— ๋”ฐ๋ผ fever threshold๋Š” ๋‹ค๋ฅผ ์ˆ˜ ์žˆ๋‹ค.
โ€ข
์ „ํ†ต์ ์œผ๋กœ 3๊ฐœ์›” ๋ฏธ๋งŒ์˜ ์˜์œ ์•„์—์„œ๋Š” 38โ„ƒ๋ฅผ ๊ธฐ์ค€
โ€ข
3๊ฐœ์›”~36๊ฐœ์›” ์†Œ์•„์—์„œ๋Š” 39โ„ƒ ์ด์ƒ์ด ์ž„์ƒ์ ์œผ๋กœ ์ค‘์š”ํ•œ fever์˜ ๊ธฐ์ค€์ด์—ˆ๋‹ค.
โ€ข
36๊ฐœ์›” ์ด์ƒ์€ ์ด ์—ฐ๋ น๋Œ€์˜ SBI์— ๋Œ€ํ•œ ์—ผ๋ ค๋กœ fever threshold๊ฐ€ ์ •ํ•ด์ ธ ์žˆ์ง€๋Š” ์•Š๋‹ค.
(3) ์•ก์™€์ฒด์˜จ์€ ๊ตฌ๊ฐ•์ฒด์˜จ๋ณด๋‹ค 0.6ยฐC ๋‚ฎ๊ฒŒ ์ธก์ •๋˜๊ณ , ๊ตฌ๊ฐ•์ฒด์˜จ์€ ์ง์žฅ์ฒด์˜จ๋ณด๋‹ค 0.6ยฐC ๋‚ฎ๊ฒŒ ์ธก์ •๋œ๋‹ค.
(4) ํ”ํ•˜๊ฒŒ ์‚ฌ์šฉํ•˜๊ณ  ์žˆ๋Š” ์ ์™ธ์„  ๊ณ ๋ง‰ ์ฒด์˜จ๊ณ„๋Š” variable reliability and reproducibility๋ฅผ ๊ฐ–๋Š”๋‹ค.

A2. Serious Bacterial Illness (SBI)

(1) 3๊ฐœ์›” ๋ฏธ๋งŒ์˜ ์˜์œ ์•„๋Š” opsonin activity, macrophage, neutrophil function์ด ๊ฐ์†Œ๋˜์–ด ์žˆ๊ณ , bone marrow insufficiency๊ฐ€ ๋™๋ฐ˜๋˜์–ด ์žˆ๋‹ค. (2) 24๊ฐœ์›” ๋ฏธ๋งŒ์˜ ์œ ์•„์—์„œ๋Š” encapsulated bacteria์— ๋Œ€ํ•œ Immunoglobulin G antibody response๊ฐ€ ๊ฐ์†Œ๋˜์–ด ์žˆ๋‹ค. (3) ์†Œ์•„์—์„œ SBI ์˜ ๊ฐ€์žฅ ํ”ํ•œ ๋ฐœํ˜„ํ˜•ํƒœ : UTI / Bacteremia / Sepsis / Pneumonia / Sinusitis / Meningitis
SBI์˜ Red Flag Sign den Bruel AV et al. Lancet 2010;375:834-45. - Cyanosis - Rapid Breathing - Poor Peripheral Perfusion - Petechial Rash - Clinician Instinct - Temperature > 40 degree : with low prevalence SBI

A3. Urinary tract infection

โ€ข
๊ฐ€์žฅ ํ”ํ•œ SBI ์›์ธ
(1) ED์— ๋ฐฉ๋ฌธํ•˜๋Š” ํ™˜์•„ ์ค‘ ๋‹ค๋ฅธ fever focus๊ฐ€ ์—†๋Š” ๊ฒฝ์šฐ 3~8%๋Š” UTI๊ฐ€ ์žˆ๋‹ค.
โ€ข
์›์ธ์ด ๋ช…ํ™•ํ•˜์ง€ ์•Š์„ ๋•Œ ์†Œ๋ณ€๊ฒ€์‚ฌ ๋ฐ ์†Œ๋ณ€ ๋ฐฐ์–‘๊ฒ€์‚ฌ๋ฅผ ๋ฐ˜๋“œ์‹œ ๊ณ ๋ คํ•œ๋‹ค.
โ€ข
2๊ฐœ์›”~2์„ธ ์œ ์•„์—์„œ 5%์˜ incidence๋ฅผ ๊ฐ–๋Š”๋‹ค.
โ€ข
Circumcised boy๋ณด๋‹ค uncirculcumcised boy์˜ incidency๊ฐ€ 5~20๋ฐฐ ๋†’๋‹ค
โ€ข
39ยฐC ์ด์ƒ์˜ fever์™€ pyuria๊ฐ€ ๋™๋ฐ˜๋œ ๊ฒฝ์šฐ APN์„ ์‹œ์‚ฌํ•œ๋‹ค.
โ€ข
ํ•ญ์ƒ์ œ๋ฅผ ์‹œ์ž‘ํ•˜๊ธฐ ์ „์— UA test ๋ฐ Urine culture๋ฅผ ์‹œํ–‰
โ€ข
์–ด๋ฆฐ ์†Œ์•„์—์„œ ์•ฝ 5~10%์˜ ๋ฐœ์—ด ๋™๋ฐ˜ UTI ์—์„œ bacteremia๊ฐ€ ์žˆ๊ธฐ์— blood or cerebrospinal fluid test๋ฅผ ๊ณ ๋ คํ•œ๋‹ค.
(2) E. coli๋‚˜ ๋‹ค๋ฅธ Gram negative bacteria๊ฐ€ ๊ฐ€์žฅ ๋งŽ์€ UTI ์›์ธ์ด๋ฉฐ, UTI๋Š” fever ์™ธ ๋‹ค๋ฅธ ์ฆ์ƒ์ด ์—†๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ๊ธฐ ๋•Œ๋ฌธ์— Neonatal fever ๋‚˜ infant fever๋ฅผ evaluation ํ•  ๋•Œ routineํ•˜๊ฒŒ Urine๊ฒ€์‚ฌ๋ฅผ ์‹œํ–‰ํ•˜๋Š” ๊ฒƒ์„ ๊ถŒ์žฅํ•œ๋‹ค.
(3) Leukocyte esterase/ Nitrate / WBC count / Gram stain and culture๋ฅผ ์‹œํ–‰
โ€ข
Leukocyte esterase (+) : sensitivity of 67% to 85% for UTI
โ€ข
Nitrite (+) : specificity of 95% to 99% for UTI
(4) Leukocyte esterase/nitrate/WBC count์—์„œ ์Œ์„ฑ์œผ๋กœ ๋‚˜์˜ค๋”๋ผ๋„ UTI risk๊ฐ€ ์žˆ๋Š” ํ™˜์•„๋Š” Gram stain ๋ฐ culture๋ฅผ ์‹œํ–‰.

A4. Bacteremia and Sepsis

(1) 3๊ฐœ์›” ๋ฏธ๋งŒ์˜ febrile infants์—์„œ bacteremia/sepsis incidence๋Š” 1~3%.
(2) 3๊ฐœ์›” ๋ฏธ๋งŒ์˜ febile infants์—์„œ bactermia/meningitis์˜ m/c ์›์ธ๊ท 
โ€ข
E.coli
โ€ข
Group B streptococcus
โ€ข
Listeria (L. monocytogenes)

(3) SBI ์›์ธ๊ท ์€ ์—ฐ๋ น์— ๋”ฐ๋ผ ๋‹ค๋ฆ„

โ€ข
3๊ฐœ์›” ๋ฏธ๋งŒ : Group B streptococcus, E. coli, Listeria ๊ฐ€ ์ฃผ์ข…
โ€ข
3๊ฐœ์›” ์ด์ƒ : S. pneumonia, N.meningitidis, S. aureus (S. pneumonia meningitis๋Š” pneumococcal conjugate vaccination์œผ๋กœ ๊ฐ์†Œ์ถ”์„ธ)
โ€ข
ํ•™๋™๊ธฐ ์†Œ์•„ : N.meningitidis๊ฐ€ ์ฃผ์ข…. Group A-hemolytic streptococcus๋„ ์ฆ๊ฐ€ ์ถ”์„ธ
(4) Hamophilus influezae type b vaccine ๋ฐ pneumococcal conjugate vaccine์˜ ์‚ฌ์šฉ์œผ๋กœ 3~36 month ์—ฐ๋ น์˜ occult(์ž ๋ณต) bactermia๊ฐ€ 0.5~0.7%๋กœ ๊ฐ์†Œํ•˜์˜€๋‹ค.

A5. Pneumonia and Sinusitis

(1) ํ๋ ด ๋ฐ ๋ถ€๋น„๋™์—ผ์€ ์†Œ์•„ ์ƒ๊ธฐ๋„๊ฐ์—ผ๊ณผ ๋™๋ฐ˜ํ•˜์—ฌ ํ”ํ•˜๊ฒŒ ์ง„๋‹จ๋œ๋‹ค.
(2) ์—ฐ๋ น๋ณ„ ํ˜ธ๋ฐœ ์›์ธ๊ท ์€ meningitis์™€ ๋™์ผํ•˜๋‹ค. (์•„๋ž˜ meningitis ์ฐธ์กฐ)
(3) 3์„ธ ์ดํ•˜์˜ ์†Œ์•„๋Š” ๋ถ€๋น„๋™ ํ˜•์„ฑ์ด ๋ถˆ์™„์ „ํ•˜์—ฌ ๋ถ€๋น„๋™์—ผ์€ ๊ฑฐ์˜ ์—†๋‹ค.
(4) ํ๋ ด์ง„๋‹จ์˜ chest PA๊ฐ€ gold standard์ด๋‚˜ ์ฆ์ƒ์—†๋Š” ํ™˜์ž์—๊ฒŒ routineํ•˜๊ฒŒ ์ฐ์„ ํ•„์š”๋Š” ์—†๋‹ค.
(5) ๋ฐœ์—ด์€ ์žˆ์ง€๋งŒ URI ์ฆ์ƒ์ด ์—†๋Š” ์†Œ์•„์—๊ฒŒ ํ๋ ด ๊ฐ€๋Šฅ์„ฑ์€ ๋งค์šฐ ๋‚ฎ๋‹ค.

A6. Meningitis

(1) ์—ฐ๋ น์— ๋”ฐ๋ผ ์›์ธ๊ท ์ด ๋‹ค๋ฆ„
โ€ข
3๊ฐœ์›” ๋ฏธ๋งŒ : E.coli, Group B streptococcus, Listeria (L. monocytogenes)
โ€ข
3๊ฐœ์›” ์ด์ƒ : S. pneumonia, N.meningitidis, S. aureus (S. pneumonia meningitis๋Š” pneumococcal conjugate vaccination์œผ๋กœ ๊ฐ์†Œ์ถ”์„ธ)
(2) CSF fluid analysis๋ฅผ ํ†ตํ•ด ์ง„๋‹จํ•œ๋‹ค.
โ€ข
CSF WBC > 30 cells/mm3 in the neonate
โ€ข
CSF WBC > 10 cells/mm3 in children > 1 month old
(3) Steroids ๋™๋ฐ˜์‚ฌ์šฉ์— ๋Œ€ํ•ด์„œ๋Š” controversial . ๋งŒ์•ฝ ํˆฌ์—ฌํ•œ๋‹ค๋ฉด ํ•ญ์ƒ์ œ ํˆฌ์—ฌ ์ „ ํˆฌ์—ฌ
(4) Aseptic meningitis๋Š” ์ผ๋ฐ˜์ ์œผ๋กœ Adm. ํ•˜์—ฌ ์น˜๋ฃŒ
โ€ข
Dehydration ๋ฐฉ์ง€ ๋ฐ subsequent neurologic and learning ability ์œ„ํ—˜์œผ๋กœ ๊ฒฝ๊ณผ ๊ด€์ฐฐ ์œ„ํ•ด
โ€ข
๊ท€๊ฐ€ํ•œ๋‹ค๋ฉด ceftriaxone 100mg/kg IM or IV ํ›„ 24์‹œ๊ฐ„ ์ด๋‚ด opd f/u์„ ํ•œ๋‹ค.
(5) Meningismus (meningeal irritation sign)
โ€ข
6๊ฐœ์›” ๋ฏธ๋งŒ์˜ infant์—์„œ unreliable ํ•˜๊ธฐ์— 2๊ฐœ์›” ๋ฏธ๋งŒ์˜ infant์—์„œ fever focus ์—†๋Š” ๊ฒฝ์šฐ routine lumbar puncture๋ฅผ ๊ถŒ๊ณ ํ•จ.
โ€ข
2~6๊ฐœ์›”์˜ infants์—์„œ๋Š” selective lumbar puncture